Alloreactive T Cell Clone Size Cells, and the + CTLA-4, CD25 Regulating Alloimmunity: Cytokines, Physiological Mechanisms of

References es http://www.jimmunol.org/cgi/content/full/169/7/3744#otherarticl15 online articles that cite this article can be accessed at: €http://www.jimmunol.org/cgi/content/full/169/7/3744#BIBL This article cites 52 articles, 28 of which can be accessed free at:Subscriptions online at http://www.jimmunol.org/subscriptions/ Information about subscribing to The Journal of Immunology isPermissions http://www.aai.org/ji/copyright.html Submit copyright permission requests at Email Alerts up at http://www.jimmunol.org/subscriptions/etoc.shtml Receive free email alerts when new articles cite this article. Sign

[1]  A. Sharpe,et al.  The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. , 1999, Journal of immunology.

[2]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[3]  C. Thompson,et al.  CTLA-4 Is Not Required for Induction of CD8+ T Cell Anergy In Vivo1 , 2001, The Journal of Immunology.

[4]  A. Sharpe,et al.  CTLA-4 regulates induction of anergy in vivo. , 2001, Immunity.

[5]  T. Mak,et al.  Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.

[6]  T. Strom,et al.  Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance , 1999, Nature Medicine.

[7]  S. Khoury,et al.  Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model. , 1999, Journal of immunology.

[8]  M. Zand,et al.  On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. , 1998, Journal of immunology.

[9]  P. Linsley,et al.  Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. , 1997, Journal of immunology.

[10]  C. Thompson,et al.  Brief Definitive Report Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Blockade Accelerates the Acute Rejection of Cardiac Allografts in CD28-deficient Mice: CTLA4 Can Function Independently of CD28 , 2022 .

[11]  Y. Zhai,et al.  What is the role of regulatory T cells in transplantation tolerance? , 1999, Current opinion in immunology.

[12]  R. Noelle,et al.  Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4. , 1998, The Journal of clinical investigation.

[13]  H. Griesser,et al.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.

[14]  R. Corry,et al.  PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE: THE ROLE OF H‐2D, H‐2K, AND NON‐H-2 ANTIGENS IN REJECTION , 1973, Transplantation.

[15]  F. Powrie,et al.  IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo1 , 2001, The Journal of Immunology.

[16]  T. Fujita,et al.  Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. , 1999, Cancer research.

[17]  A. Abbas,et al.  Homeostasis and self-tolerance in the immune system: turning lymphocytes off. , 1998, Science.

[18]  T. Strom,et al.  Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance , 1999, Nature Medicine.

[19]  S. Khoury,et al.  Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. , 2001, The Journal of clinical investigation.

[20]  T. Sullivan,et al.  Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. , 1997, Immunity.

[21]  G. Remuzzi,et al.  Challenges to achieving clinical transplantation tolerance. , 2001, The Journal of clinical investigation.

[22]  S. Khoury,et al.  The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. , 2000, The Journal of clinical investigation.

[23]  T. Mak,et al.  Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. , 1998, Journal of immunology.

[24]  M. Isobe,et al.  Treatment of murine cardiac allograft by monoclonal antibodies to IL-2 receptor α chain and β chain☆ , 1997 .

[25]  Fiona Powrie,et al.  Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation , 2000, The Journal of experimental medicine.

[26]  R. Clark,et al.  Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Kupiec-Weglinski,et al.  Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells. , 1989, Journal of immunology.

[28]  J. Bluestone,et al.  CTLA-4 regulates tolerance induction and T cell differentiation in vivo. , 1998, Journal of immunology.

[29]  C. Thompson,et al.  Expression and function of CTLA-4 in Th1 and Th2 cells. , 1998, Journal of immunology.

[30]  M. Sayegh,et al.  New Insights Into the Interactions Between T-Cell Costimulatory Blockade and Conventional Immunosuppressive Drugs , 2002, Annals of surgery.

[31]  D. Anthony,et al.  T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. , 1998, The Journal of clinical investigation.

[32]  J. Bluestone,et al.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. , 2001, Annual review of immunology.

[33]  P. Nickerson,et al.  Prolonged islet allograft acceptance in the absence of interleukin 4 expression. , 1996, Transplant immunology.

[34]  Z. Dai,et al.  Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. , 1998, Journal of immunology.

[35]  H. Auchincloss,et al.  In vivo use of monoclonal antibodies against murine T cell antigens. , 1989, Clinical immunology and immunopathology.

[36]  T. Strom,et al.  Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. , 1997, Immunity.

[37]  A. Valujskikh,et al.  Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. , 1998, Journal of immunology.

[38]  M. Kaplan,et al.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.

[39]  E. Shevach,et al.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. , 1998, Journal of immunology.

[40]  P. Linsley,et al.  IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. , 1998, Journal of immunology.

[41]  R. Maki,et al.  Role of interleukin 12 and costimulators in T cell anergy in vivo , 1997, The Journal of experimental medicine.

[42]  P. Linsley,et al.  CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2 , 1995, The Journal of experimental medicine.

[43]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[44]  F. Alt,et al.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.

[45]  A. Sharpe,et al.  CTLA-4 and T cell activation. , 1999, Current opinion in immunology.

[46]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[47]  J. Egen,et al.  CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. , 2001, Annual review of immunology.

[48]  M. Kaplan,et al.  Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice , 1996, Nature.

[49]  B. Hall,et al.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action , 1990, The Journal of experimental medicine.

[50]  D. Abramowicz,et al.  CRITICAL ROLE OF INTERLEUKIN 4 IN THE INDUCTION OF NEONATAL TRANSPLANTATION TOLERANCE , 1995, Transplantation.